LDCT screening results among eligible and ineligible screening candidates in preventive health check-ups population: a real world study in West China

Abstract To compare the LDCT screening results between eligible and ineligible screening candidates in preventive health check-ups population. Using a real-world LDCT screening results among people who took yearly health check-up in health management center of West China Hospital between 2006 and 20...

Full description

Bibliographic Details
Published in:	Scientific Reports
Main Authors:	Ting Bao, Bingqing Liu, Ruicen Li, Zhenzhen Li, Guiyi Ji, Youjuan Wang, Hanwei Yang, Weimin Li, Wenxia Huang, Yan Huang, Huairong Tang
Format:	Article
Language:	English
Published:	Nature Portfolio 2024-02-01
Subjects:	Lung cancer screening Low-dose spiral CT Ineligible screening candidates False-positive biopsy
Online Access:	https://doi.org/10.1038/s41598-024-55475-x

Similar Items

Socioepidemiological screening of serologically ineligible blood donors due to Chagas disease for the definition of inconclusive cases
by: Márcia M Ferreira-Silva, et al.
Published: (2010-09-01)

Significance of GPT-enabled LDCT lung cancer screening
by: Shixiong Yang, et al.
Published: (2025-12-01)

Long‐term follow‐up of outcomes including progression‐free survival 2 in patients with transplant‐ineligible multiple myeloma in the real‐world practice: A multi‐institutional report from the Canadian Myeloma Research Group (CMRG) database
by: Rayan Kaedbey, et al.
Published: (2024-06-01)

Revisiting Treatment of Metastatic Urothelial Cancer: Where Do Cisplatin and Platinum Ineligibility Criteria Stand?
by: Mohammad Jad Moussa, et al.
Published: (2024-02-01)

Daratumumab-based immunotherapy vs. lenalidomide, bortezomib and dexamethasone in transplant-ineligible newly diagnosed multiple myeloma: a systemic review
by: Wenjiao Tang, et al.
Published: (2024-01-01)

Chidamide Maintenance Therapy Following Induction Therapy in Patients With Peripheral T-Cell Lymphoma Who Are Ineligible for Autologous Stem Cell Transplantation: Case Series From China
by: Wei Guo, et al.
Published: (2022-06-01)

The efficacy and safety of first-line treatment in cisplatin-ineligible advanced upper tract urothelial carcinoma patients: a comparison of PD-1 inhibitor and carboplatin plus gemcitabine chemotherapy
by: Jiwei Huang, et al.
Published: (2022-12-01)

The Role of Monoclonal Antibodies in the First-Line Treatment of Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma
by: Francesca Bonello, et al.
Published: (2020-12-01)

Venetoclax with low-dose cytarabine, a forgotten combination in patients with acute myeloid leukemia ineligible for intensive chemotherapy: a systematic review
by: Lauro Fabián Amador-Medina, et al.
Published: (2024-12-01)

Prevalence and correlates of false-positive results after 3-D screening mammography among uninsured women in a community outreach program
by: Rasmi G. Nair, et al.
Published: (2022-06-01)

Advance of Lung Cancer Screening with Low-dose Spiral CT
by: Guanhua REN, et al.
Published: (2013-10-01)

Healthcare professionals' experiences of caring for women with false‐positive screening test results in the National Health Service Breast Screening Programme
by: Hannah A. Long, et al.
Published: (2024-04-01)

False Negative Results in Cervical Cancer Screening—Risks, Reasons and Implications for Clinical Practice and Public Health
by: Anna Macios, et al.
Published: (2022-06-01)

Innovative Spiral Vibrating Screen for High-Quality Cubical Crushed Stone: Design and Validation
by: Darkhan Yelemes, et al.
Published: (2025-09-01)

Assessing factors influencing participation in LDCT lung cancer screening among high-risk urban populations in Nanjing, China
by: Meijing Liu, et al.
Published: (2025-07-01)

The majority of patients with resectable incidental lung cancers are ineligible for lung cancer screeningCentral MessagePerspective
by: Nanruoyi Zhou, MD, et al.
Published: (2023-03-01)

Cost-effectiveness analysis of atezolizumab in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen: a United Kingdom health care perspective
by: Yunlin Jiang, et al.
Published: (2023-09-01)

Large Diameter and Fast Plug-in Type Spiral Drill Pipe for Drilling Down Screen Pipe Without Lifting
by: YANG Huwei
Published: (2020-09-01)

Breast cancer survivors' risk of interval cancers and false positive results in organized mammography screening
by: Sisse Helle Njor, et al.
Published: (2020-08-01)

Phase II Trial of Romidepsin as Consolidation Therapy after Gemcitabine, Dexamethasone, and Cisplatin in Elderly Transplant-Ineligible Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma
by: Satoshi Yamasaki, et al.
Published: (2024-05-01)

Quantile-Adaptive Sufficient Variable Screening by Controlling False Discovery
by: Zihao Yuan, et al.
Published: (2023-03-01)

Retrospective Review of Positive Newborn Screening Results for Isovaleric Acidemia and Development of a Strategy to Improve the Efficacy of Newborn Screening in the UK
by: Rachel S. Carling, et al.
Published: (2024-03-01)

Application of artificial intelligence in lung cancer screening: A real‐world study in a Chinese physical examination population
by: Jiaxuan Wu, et al.
Published: (2024-10-01)

Results of a pilot risk-based lung cancer screening study: outcomes and comparisons to a Medicare eligible cohort
by: Erin A. Hirsch, et al.
Published: (2023-08-01)

Psychosocial Impact of False-Positive Newborn Screening Results: A Scoping Review
by: Jane Chudleigh, et al.
Published: (2024-04-01)

Opioid-positive urine drug screen during treatment with oral naltrexone and the clinical implications
by: Elena R. Beauregard, PharmD, BCPS, et al.
Published: (2024-04-01)

False positive values of biomarkers of prenatal screening on chromosomopathy as indicators of a risky pregnancy
by: Durković Jasmina, et al.
Published: (2011-01-01)

Impact of U.S. Preventive Services Task Force lung cancer screening update on drivers of disparities in screening eligibility
by: Kristin G. Maki, et al.
Published: (2023-02-01)

Developing an explainable machine learning model to predict false-negative citrin deficiency cases in newborn screening
by: Peiyao Wang, et al.
Published: (2025-10-01)

Reasons for truly negative cytology reports preceding the diagnoses of invasive cervical cancer—Results of a false‐negative cytology audit in Polish Cervical Cancer Screening Programme
by: Anna Macios, et al.
Published: (2023-06-01)

Opioid false-positivity in urine drug screening: levomepromazine cross-reactivity
by: Nuno Rodrigues-Silva, et al.
Published: (2017-01-01)

False negatives of screening in large-scale population
by: XU Ning, et al.
Published: (2022-05-01)

Effectiveness Evaluation of Low-dose Spiral Computed Tomography  for Lung Cancer Screening in Minhang District of Shanghai
by: Jiaoyue TENG, et al.
Published: (2024-01-01)

Effectiveness and safety of immune checkpoint inhibitor monotherapy in advanced upper tract urothelial carcinoma: A multicenter, retrospective, real‐world study
by: Ruopeng Su, et al.
Published: (2023-05-01)

Upfront blood microRNA test in LDCT-reluctant individuals: insights from the biomild trial
by: Gabriella Sozzi, et al.
Published: (2025-05-01)

dbRUSP: An Interactive Database to Investigate Inborn Metabolic Differences for Improved Genetic Disease Screening
by: Gang Peng, et al.
Published: (2022-08-01)

Postnatal corticosteroid treatment as a risk factor for false positivity in severe combined immunodeficiency newborn screening
by: Po-Sung Chen, et al.
Published: (2023-08-01)

Cystic Fibrosis Newborn Screening in Austria Using PAP and the Numeric Product of PAP and IRT Concentrations as Second-Tier Parameters
by: Maximilian Zeyda, et al.
Published: (2021-02-01)

Investigate how frequently dental professionals conduct oral cancer screenings during routine dental check-ups and the methods they use
by: Sindhu Sudhakar Kumararama, et al.
Published: (2024-01-01)

Evaluating the Impact of Newborn Screening for Cystic Fibrosis in Portugal: A Decade of Insights and Outcomes
by: Bernardo Camacho, et al.
Published: (2025-08-01)